Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2022 Oct;9(1):e000711.
doi: 10.1136/lupus-2022-000711.

Impact of severe infections in SLE: an observational study from the Spanish national registry

Affiliations
Observational Study

Impact of severe infections in SLE: an observational study from the Spanish national registry

Victor Moreno-Torres et al. Lupus Sci Med. 2022 Oct.

Abstract

Objective: Infections are a common complication of SLE. Our objective was to evaluate their causes and impact on the survival of patients with SLE.

Methods: Analysis of the admissions and death causes in patients diagnosed with SLE from the Spanish Hospital Discharge Database and the infection-related deaths of the Spanish population from the National Statistical Institute, between 2016 and 2018.Only infections recorded as the main diagnosis were analysed (severe or clinically relevant infection).

Results: Among 18 430 admissions in patients with SLE, disease activity was the cause of admission in 19% of all patients and infection in 15%. However, infection was the main cause of death (25%) while SLE activity was responsible for only 6% of deaths (p<0.001). Severe infection exceeded SLE as a cause of death for patients dying at ages between 40-59 (23% vs 4%, p<0.001), 60-79 (26% vs 6%, p<0.001) and older than 80 years (25% vs 6%, p<0.001). Infection was the cause of death in 8% of the Spanish population, a significantly lower rate when compared with patients with SLE (p<0.001). Compared with the general population, infections were the highest relative cause of death in patients with SLE, particularly at younger ages: 40% vs 3% for those below 20 years old (p<0.01), 33% vs 4% between 20 and 39 (p<0.001), 23% vs 5% between 40 and 59 (p<0.001), 26% vs 5% between 60 and 79 (p<0.001) and 25% vs 9% for those older than 80 years (p<0.001).

Conclusion: Our nationwide study confirms that infections are the leading cause of death in SLE in Spain, with the highest proportion occurring in young patients with lupus compared with the general population of the same age range.

Keywords: epidemiology; glucocorticoids; systemic lupus erythematosus.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Deaths attributable to infection versus SLE activity, among hospital-admitted patients with SLE, for each age period. Data are expressed as a percentage of death for all causes among patients with SLE, for each age period. *Differences statistically significant (χ2 test).
Figure 2
Figure 2
Infection-related deaths, among patients with SLE and the Spanish population, for each age period. Data are expressed as a percentage of death for all causes among patients with SLE and the overall Spanish population, for each age period. *Differences statistically significant (χ2 test).

References

    1. Lisnevskaia L, Murphy G, Isenberg D. Systemic lupus erythematosus. Lancet 2014;384:1878–88. 10.1016/S0140-6736(14)60128-8 - DOI - PubMed
    1. Kaul A, Gordon C, Crow MK, et al. . Systemic lupus erythematosus. Nat Rev Dis Primers 2016;2:16039. 10.1038/nrdp.2016.39 - DOI - PubMed
    1. Arnaud L, Tektonidou MG. Long-Term outcomes in systemic lupus erythematosus: trends over time and major contributors. Rheumatology 2020;59:v29–38. 10.1093/rheumatology/keaa382 - DOI - PMC - PubMed
    1. Bernatsky S, Boivin J-F, Joseph L, et al. . Mortality in systemic lupus erythematosus. Arthritis Rheum 2006;54:2550–7. 10.1002/art.21955 - DOI - PubMed
    1. Fors Nieves CE, Izmirly PM. Mortality in systemic lupus erythematosus: an updated review. Curr Rheumatol Rep 2016;18:21. 10.1007/s11926-016-0571-2 - DOI - PubMed

Publication types